HROW HROW

Harrow Health Stock Price

FREE HROW REPORT

14.47
-0.58 (-3.85%)
Upgrade to Real-Time
Afterhours (Closed)
14.47
Volume 207,528
Bid Price 14.33
Ask Price 15.74
News -
Day High 15.22

Low
5.40

52 Week Range

High
15.59

Day Low 14.20
Company Name Stock Ticker Symbol Market Type
Harrow Health Inc HROW NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.58 -3.85% 14.47 17:07:27
Open Price Low Price High Price Close Price Prev Close
15.17 14.20 15.22 14.47 15.05
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
2,805 207,528 $ 14.62 $ 3,033,700 - 5.40 - 15.59
Last Trade Time Type Quantity Stock Price Currency
17:07:26 38 $ 14.38 USD

Period:

Draw Mode:

Harrow Health Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 431.06M 29.79M 24.50M $ 72.48M $ -16.08M -0.68 -18.70
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 405.54k 19.80%

more financials information »

Harrow Health News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical HROW Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week14.0015.5913.8714.75202,0100.473.36%
1 Month13.7215.5913.5414.45238,3780.755.47%
3 Months12.3115.5910.0612.96230,6962.1617.55%
6 Months6.6515.596.5011.83198,0817.82117.59%
1 Year7.6515.595.4010.30145,4806.8289.15%
3 Years6.9615.593.338.27166,4427.51107.9%
5 Years5.4215.593.337.55184,1149.05166.97%

Harrow Health Description

Harrow Health Inc is an ophthalmology-focused pharmaceutical company. The company is specialized in the development, production, and sale of medications that offer competitive advantages and serve unmet needs in the marketplace. Its cornerstone of ophthalmology program consists of proprietary Dropless Therapy injectable and LessDrops topical formulations that are designed to address patient compliance issues and provide other compelling medical and economic benefits.